COVID-19: loss of bridging between innate and adaptive immunity?

dc.creatorRao, Vishal U. S.
dc.creatorArakeri, Gururaj
dc.creatorSubash, Anand
dc.creatorRao, Jyothsna
dc.creatorJadhav, Sachin
dc.creatorSuhail Sayeed, Mufti
dc.creatorRao, Gururaj
dc.creatorBrennan, Peter A.
dc.date2020-06-22T19:04:31Z
dc.date2020-06-22T19:04:31Z
dc.date2020-11
dc.date.accessioned2023-09-28T19:54:38Z
dc.date.available2023-09-28T19:54:38Z
dc.identifierRAO, V. U. S. et al. COVID-19: loss of bridging between innate and adaptive immunity? Medical Hypotheses, [S.l.], v. 144, Nov. 2020.
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S030698772030863X
dc.identifierhttp://repositorio.ufla.br/jspui/handle/1/41524
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9039915
dc.descriptionCOVID-19 has spread to most countries in the world. However, there are some striking differences in how COVID-19 is behaving in different age groups. While data on COVID-19 is limited, children appear to be less susceptible to severe disease. These unique characteristics may be considered as a potential link to understanding the immune system and response in COVID-19 and lead to an effective cure to the disease. We suggest a possible role of loss of bridging between innate and adaptive immunity in COVID-19 and a potential treatment modality also discussed.
dc.languageen_US
dc.publisherElsevier
dc.rightsrestrictAccess
dc.sourceMedical Hypotheses
dc.subjectCOVID-19
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
dc.subjectAdaptive immunity
dc.subjectInnate immunity
dc.subjectCytokines
dc.subjectInterferons (IFNs)
dc.titleCOVID-19: loss of bridging between innate and adaptive immunity?
dc.typeArtigo


Este ítem pertenece a la siguiente institución